Quick Answer
BIO KEY INTERNATIONAL INC reported Total Revenue of $6.30 million for fiscal year 2017.
BIO KEY INTERNATIONAL INC — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$4.30M +49.5% |
-$8.52M +28.4% |
-$11.91M -135.1% |
-$5.07M +47.6% |
-$9.67M +33.7% |
-$14.59M -112.4% |
| Total Assets | $8.62M +90.7% |
$4.52M -60.2% |
$11.34M -36.2% |
$17.77M -21.1% |
$22.52M +802.0% |
$2.50M -78.6% |
| Cash and Equivalents | $437.6K -14.4% |
$511.4K -80.6% |
$2.64M -66.0% |
$7.75M -54.4% |
$16.99M +21406.7% |
$79.0K -75.6% |
| Long-Term Debt | $44.8K -76.3% |
$188.8K -42.2% |
$326.8K | $0.00 | — | — |
| Stockholders Equity | $3.77M +0.4% |
$3.76M -29.1% |
$5.30M -66.0% |
$15.62M -23.2% |
$20.34M +989.9% |
-$2.29M -121.8% |
| R&D Expense | $2.51M +4.9% |
$2.39M -26.4% |
$3.25M +38.1% |
$2.36M +68.6% |
$1.40M +4.9% |
$1.33M -5.9% |
| Operating Income | -$4.01M +54.6% |
-$8.83M +11.1% |
-$9.92M -100.8% |
-$4.94M +5.0% |
-$5.20M -386.7% |
-$1.07M -1336325.0% |
| Gross Profit | $5.64M +294.1% |
$1.43M -68.8% |
$4.58M +33.1% |
$3.44M +68.5% |
$2.04M +1154.1% |
-$193.7K -61.9% |
| Shares Outstanding | 3.72M +259.8% |
1.03M +86.8% |
552,739 -93.0% |
7.85M +0.5% |
7.81M +331.2% |
1.81M -87.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2017 | $942.4K | +118.4% | +6.3% |
| Net Income | September 30, 2025 | -$964.8K | -30.6% | +17.4% |
| Diluted EPS | June 30, 2013 | -$0.01 | +0.0% | — |
| Total Assets | September 30, 2025 | $10.11M | +58.0% | -3.8% |
| Cash and Equivalents | September 30, 2025 | $2.04M | +13.3% | -10.3% |
| Long-Term Debt | June 30, 2025 | $0.00 | -100.0% | -100.0% |
| Stockholders Equity | September 30, 2025 | $6.05M | +4443.7% | -11.8% |
| R&D Expense | September 30, 2025 | $683.6K | +4.8% | +7.5% |
| Operating Income | September 30, 2025 | -$892.2K | -53.7% | +17.7% |
| Gross Profit | September 30, 2025 | $1.19M | -29.1% | -3.3% |
| Shares Outstanding | September 30, 2025 | 7.31M | +135.2% | +6.8% |
- BIO KEY INTERNATIONAL INC reported Total Revenue of $6.30 million for fiscal year 2017.
- BIO KEY INTERNATIONAL INC showed an increase of +111.8% in Total Revenue compared to the prior fiscal year.
- BIO KEY INTERNATIONAL INC reported Net Income of -$4.30 million for fiscal year 2024.
- BIO KEY INTERNATIONAL INC showed an increase of +49.5% in Net Income compared to the prior fiscal year.
- BIO KEY INTERNATIONAL INC reported Total Assets of $8.62 million for fiscal year 2024.
- BIO KEY INTERNATIONAL INC showed an increase of +90.7% in Total Assets compared to the prior fiscal year.
- BIO KEY INTERNATIONAL INC reported Cash and Equivalents of $437.6 thousand for fiscal year 2024.
- BIO KEY INTERNATIONAL INC showed a decrease of -14.4% in Cash and Equivalents compared to the prior fiscal year.
- BIO KEY INTERNATIONAL INC reported Long-Term Debt of $44.8 thousand for fiscal year 2024.
- BIO KEY INTERNATIONAL INC showed a decrease of -76.3% in Long-Term Debt compared to the prior fiscal year.
- BIO KEY INTERNATIONAL INC reported Stockholders Equity of $3.77 million for fiscal year 2024.
- BIO KEY INTERNATIONAL INC showed an increase of +254.7% in Stockholders Equity compared to the prior fiscal year.
- BIO KEY INTERNATIONAL INC reported R&D Expense of $2.51 million for fiscal year 2024.
- BIO KEY INTERNATIONAL INC showed an increase of +4.9% in R&D Expense compared to the prior fiscal year.
- BIO KEY INTERNATIONAL INC reported Operating Income of -$4.01 million for fiscal year 2024.
- BIO KEY INTERNATIONAL INC showed an increase of +54.6% in Operating Income compared to the prior fiscal year.
- BIO KEY INTERNATIONAL INC reported Gross Profit of $5.64 million for fiscal year 2024.
- BIO KEY INTERNATIONAL INC showed an increase of +294.1% in Gross Profit compared to the prior fiscal year.
- BIO KEY INTERNATIONAL INC reported Shares Outstanding of 3.72 million shares for fiscal year 2024.
- BIO KEY INTERNATIONAL INC showed an increase of +259.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: